News + Filings Transactions
|
Lucchese Cynthia L
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/18/2023 | Inari Medical, Inc. | NARI | Grant | Common Stock | 2.4k | $0.00 | $0 | | 05/18/2023 |
| 04/01/2023 | COOPER COMPANIES, INC. | COO | Grant | Restricted Stock Units | 723 | $0.00 | $0 | | 04/01/2023 |
| 04/01/2023 | COOPER COMPANIES, INC. | COO | Exercise | Restricted Stock Units | 512 | $0.00 | $0 | | 04/01/2023 |
| 10/03/2022 | HANGER, INC. | HNGR | Disposition | Common Stock | 67.9k | $18.75 | $1.3M | | 10/03/2022 |
| 10/01/2022 | COOPER COMPANIES, INC. | COO | Grant | Restricted Stock Units | 512 | $0.00 | $0 | | 10/01/2022 |
| 06/02/2022 | HANGER, INC. | HNGR | Grant | Common Stock | 9.9k | $0.00 | $0 | | 06/02/2022 |
| 05/26/2022 | Inari Medical, Inc. | NARI | Grant | Common Stock | 2.4k | $0.00 | $0 | | 05/26/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Option (right to buy) | 3.2k | $28.58 | $92k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Option (right to buy) | 5.2k | $23.02 | $119.1k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Option (right to buy) | 3.4k | $21.00 | $71.2k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Option (right to buy) | 5.7k | $16.50 | $94.6k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Option (right to buy) | 12.5k | $13.79 | $172.4k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Option (right to buy) | 9.7k | $11.84 | $114.4k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Option (right to buy) | 25k | $11.12 | $278k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Options (Right to buy) | 3.5k | $42.05 | $146k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Options (Right to buy) | 2.8k | $33.95 | $95k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Options (Right to buy) | 12.5k | $27.45 | $343.1k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Options (Right to buy) | 6k | $26.05 | $157.2k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Options (Right to buy) | 7.6k | $13.05 | $98.8k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Common Stock | 16.4k | $28.25 | $462.8k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Common Stock | 3.2k | $28.25 | $91.5k | | 05/13/2022 |
| 06/03/2021 | Intersect ENT, Inc. | XENT | Grant | Common Stock | 3.2k | $0.00 | $0 | | 06/03/2021 |
| 06/03/2021 | Intersect ENT, Inc. | XENT | Grant | Stock Option (right to buy) | 5.7k | $16.50 | $94.6k | | 06/03/2021 |
| 05/27/2021 | Inari Medical, Inc. | NARI | Grant | Common Stock | 1.4k | $0.00 | $0 | | 05/27/2021 |
| 05/26/2021 | HANGER, INC. | HNGR | Grant | Common Stock | 5.5k | $0.00 | $0 | | 05/26/2021 |
| 03/16/2021 | Intersect ENT, Inc. | XENT | Grant | Stock Option (right to buy) | 3.4k | $21.00 | $71.2k | | 03/16/2021 |
| 06/04/2020 | Intersect ENT, Inc. | XENT | Grant | Common Stock | 5k | $0.00 | $0 | | 06/04/2020 |
| 06/04/2020 | Intersect ENT, Inc. | XENT | Grant | Stock Option (right to buy) | 9.7k | $11.84 | $114.4k | | 06/04/2020 |
| 05/27/2020 | Inari Medical, Inc. | NARI | Purchase | Common Stock | 28.1k | $19.00 | $533.7k | | 05/27/2020 |
| 05/20/2020 | HANGER, INC. | HNGR | Grant | Common Stock | 8.2k | $0.00 | $0 | | 05/20/2020 |
| 06/04/2019 | Intersect ENT, Inc. | XENT | Grant | Common Stock | 2.3k | $0.00 | $0 | | 06/04/2019 |
| 06/04/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (right to buy) | 5.2k | $23.02 | $119.1k | | 06/04/2019 |
| 05/23/2019 | HANGER, INC. | HNGR | Grant | Common Stock | 7k | $0.00 | $0 | | 05/23/2019 |
| 01/16/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (right to buy) | 3.2k | $28.58 | $92k | | 01/16/2019 |
| 06/05/2018 | Intersect ENT, Inc. | XENT | Grant | Stock Options (Right to buy) | 3.5k | $42.05 | $146k | | 06/05/2018 |
|
|